Novozymes A/S and DSM N.V. sign license agreement concerning phytase feed enzyme

14-Jan-2002

Novozymes and DSM announce the signing of an agreement under which DSM grants a worldwide, semi-exclusive license and other rights to Novozymes for Novozymes' phytase products. The agreement settles a number of lawsuits filed in several countries, relating to the infringement and validity of phytase patents owned by DSM. All pending litigations relating to these patents have hereby been settled.

Phytase is an enzyme that is added to animal feed, mainly for pigs and chickens. It increases the nutritional value of the feed and at the same time reduces the environmentally harmful effects of phosphorus from animal manure. Phytase reduces the need for other phosphorous sources by allowing the animal to use the phosphate already present in animal feed cereals.

The market for phytase enzymes used in animal feed is growing rapidly and both DSM and Novozymes will continue their respective businesses within this area.

Under the terms of the agreement, Novozymes will pay DSM a significant upfront license fee and a royalty. The terms of the agreement will not be disclosed.

DSM is the originator of the first phytase product (Natuphos®) for animal feed applications, which was introduced on the market some ten years ago. DSM has built a strong patent portfolio for its phytase products. After several years of legal disputes between the two companies, DSM and Novozymes are pleased to conclude a license agreement on the DSM phytase technology.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!